S.1390

Idaho S1390 revises reporting requirements for entities participating in the 340B drug pricing program.

Idaho S1390 amends existing law to revise provisions regarding 340B drug pricing program reporting. It mandates that 340B covered entities report specific information annually to the state department of health and welfare, the state controller's office, and the attorney general. The required information includes the entity's name, acquisition costs for drugs obtained under the 340B program, payment amounts for drugs dispensed to patients, and how savings from the program are used. The data must be submitted by payer type, including commercial, Medicaid, and Medicare.